Notably, nuclear ARMC12 immunostaining was also observed in the specimens of breast cancer, colon cancer, hepatocellular carcinoma, lung cancer, pancreas cancer, prostate cancer, renal cancer, and gastric cancer, but not in their normal counterparts (Supplementary Fig. 2b). This evidence concerns the gene ARMC12 and breast carcinoma.